The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.

J Exp Clin Cancer Res · 2018 · PMC5963190 · PMID 29784019

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significanceP = 0.058so close (0.05 < p ≤ 0.1)

The expression of BRCA1 was significantly associated with shorter RFS and showed borderline significance for OS (OS; P = 0.058, RFS; P = 0.013) (Table 2 ) (Fig. 2a ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.